Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of DWKH in Acute Bronchitis
NCT05683951Phase 3Completed
- Sponsor
- Daewon Pharm
- Start
- Nov 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of DWKH in acute bronchitis (3 arms), sponsored by Daewon Pharm. Primary endpoint: Bronchitis Severity Score at 7 days. Started Nov 2021; status: completed.
02
Drugs
DWKH
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on NCT05683951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05683951.